GENERAL GUIDANCE FOR THE ADMINISTRATION OF VACCINES
Introduction
The principal aims of immunisation are threefold:



To protect the individual from infectious diseases with associated mortality,
morbidity and long-term sequelae.
To prevent outbreaks of disease.
Ultimately to eradicate infectious diseases world-wide, as in the case of
smallpox.
Registered Nurses are the major force in administering vaccine, not only within the
childhood immunisation programme but also increasingly in administering travel
vaccines and in the annual influenza campaign.
General Information
Nurses must ensure that the following procedures are carried out on each
immunisation:
 Assess patients’ suitability for the vaccine
 Consult the patients’ records if available
 Advise on possible side effects
 Answer patient queries
 Obtain patient informed consent (see consent section for more information)
 Administer vaccine
 Complete all documentation
The Nurse must:
 Confirm patient’s identity
 Ensure the identity or the vaccine must be checked to ensure the right
product is used in the appropriate way on EVERY OCCASION.
 Check the expiry date. Vaccines must not be used after the expiry date on
the label.
 Ensure that the date of immunisation, title of vaccine and batch number is
recorded on the recipient’s records.
 When two or more vaccines are given at the same time, the relevant sites
must be recorded against the vaccine given to allow any reaction to be
related to the correct vaccine given at that site.
121002 Intro to PGDs October 2012 v1


It is considered good practice to record all sites at administration.
Recommended storage conditions must be observed at all times.

Black triangle vaccines can be given under PGDs, provided they are used
in accordance with the schedules recommended by the Joint Committee
on Vaccination and Immunisation (JCVI).
Unlicensed vaccines that do not have a Marketing Authorisation
(previously known as a Product License) in the UK CANNOT be given
under PGD.
If vaccines are outside 2 to 8 0C and manufacturers can guarantee
immunogenicity the vaccines are outside of license please refer to the GP
(or Community Nursing Manager) as these vaccines can only be
administered via a Patient Specific Direction (PSD).


The Nurse should ensure:
 Neither the vaccine nor the diluent has passed its expiry date.
 Each dose is drawn up as required.
 Only one type of vaccine is mixed in each syringe, unless specifically
stated by the manufacturer.
 Any vaccine which contains particles or whose colour differs from the
description, in line with the manufacturer’s guidance, must be discarded.
Reconstitution










Where a vaccine has to be reconstituted prior to administration, when
available USE ONLY the diluent supplied.
When a vaccine does not need to be reconstituted, follow manufacturer’s
recommendation.
Note the timescale that the vaccine has to be given once reconstituted
(usually one to four hours).
A green needle (21G x 38mm - 1½ inch) should be used to draw up the
diluent and to inject it slowly into the ampoule containing the vaccine.
Draw the appropriate dose up into a clean syringe and change the needle
to the appropriate size and gauge for administration to the specific patient.
When removing liquid from a vacuum-sealed ampoule, first inject the
equivalent measure of air to the volume of liquid to be removed.
When drawing up from a glass ampoule, use a needle gauge no larger
than 21G to eliminate the possibility of glass fragments being drawn up.
Where possible change a needle after it has passed through a rubber bung
before administration to a patient.
For quantities less than 1ml use a graduated 1 ml syringe.
Discard unused reconstituted vaccines at the end of the session or if the
vaccine exceeds recommended timescale for use.
121002 Intro to PGDs October 2012 v1


The correct length and gauge of the needle are key in ensuring that the
vaccine is delivered to the correct location as painlessly as possible and
with maximum immunogenicity.
The colour on the hub of the needle refers to the gauge rather than the
length of the needle.
Standard UK Needle Gauge and Length
Colour
Length - metric
Length imperial
Gauge
Orange
Orange
Orange
Blue
Green
10 mm
16 mm
25 mm
25 mm
38 mm
3/8 inch
5/8 inch
1 inch
1 inch
1½ inches
25
25
25
23
21




A 25mm needle length is preferable and suitable for all ages
16mm needle length is only recommended for pre-term or very small
infants
In larger adults, a longer length (38mm) may be required – individually
assess patients
The width of the needle (gauge) may also need to be considered. A 23gauge or 25-gauge needle is recommended for intramuscular
administration of most vaccines. For intramuscular injections in infants,
children and adults, therefore, a 25mm 23G (blue) or 25mm 25G (orange)
needle should be used.
Administration
Vaccines are routinely given intramuscularly into the upper arm or anterolateral thigh.
For individuals with a bleeding disorder, however, vaccines should be given by deep
subcutaneous injection to reduce the risk of bleeding.
A doctor may delegate responsibility for immunisation to a registered nurse under the
conditions of a Patient Group Direction.
Whilst there is no legal requirement for a doctor to remain within the premises whilst
immunisations are administered, this procedure should only be performed by the
nurse involved if she feels competent to undertake the task and there is another
member of staff in the surgery to summon emergency help if necessary.
121002 Intro to PGDs October 2012 v1
Very premature infants (born ≤ 28 weeks of gestation) who are in hospital should
have respiratory monitoring for 48-72 hrs when given their first immunisation,
particularly those with a previous history of respiratory immaturity. If the child has
apnoea, bradycardia or desaturations after the first immunisation, the second
immunisation should also be given in hospital, with respiratory monitoring for 48-72
hrs.
Immunisation in the Home







Vaccination in the home must only be carried out with the agreement
between the General Practitioner and the Provider Organisation.
Nurses will ensure that resuscitation equipment is available on site at the
time of immunisation and any action in the event of a collapse is in
accordance with the training received.
Recipients of any vaccine should be observed for any adverse reactions
and should remain under observation until they have been seen to be in
good health and not to be experiencing an immediate adverse reaction.
The nurse must ensure that there is a competent person on site to obtain
medical support in an emergency situation.
If the home does not have a telephone, a mobile telephone must be
available.
If the immuniser has any concern, the immunisation must be delayed.
Any difficulties must be communicated to the appropriate senior manager
without delay.
Immunisation in the School Setting




Two practitioners must be present either 2 nurses or doctor/nurse.
Practitioners must wait on the school premises for 30 minutes after the last
vaccine has been administered.
Practitioners must inform the school of action to be taken in the event of a
vaccinated child having an adverse reaction.
A letter of explanation must be written to the parent of any child excluded
from vaccination.
121002 Intro to PGDs October 2012 v1
Consent
General
Consent must be obtained before starting any treatment or physical investigation or
before providing personal care for a patient. This includes the administration of
all vaccines.
The giving and obtaining of consent is viewed as a process and not a one-off event.
There is not legal requirement for consent to be in writing and a signature on a
consent form is not conclusive proof that consent has been given, but serves to
record the decision and the discussions that have taken place with the patient or
the person giving consent on a child’s behalf.
Consent obtained before the occasion upon which a child is brought for immunisation
is only an agreement for the child to be included in the immunisation programme and
does not mean that consent is in place for each future immunisation. Where the
immunisation consists of a series of injections consent will be sought for the series as
a whole, however this does not remove the requirement to re-affirm consent on each
occasion the vaccine is administered.
For single course vaccines consent should be still sought on the occasion of each
immunisation visit.
How consent should be sought
The health professional providing the immunisation should ensure that there is
consent.
The process of obtaining consent for vaccination should be the same whether the
consent obtained is written, verbal or implied (e.g. holding out an arm to be
vaccinated). Before the patient can make their decision they need to have a clear
explanation and an opportunity to ask questions about:
 The need for vaccination
 The vaccine and number of doses required
 The risks associated with the disease the patient is being immunised
against
 The risks/side effects associated with the vaccine
It is good practice to check that the person still consents to you providing each
immunisation before it is given.
The Nursing and Midwifery Council’s The Code: Standards of Conduct, Performance
and Ethics for Nurses and Midwives (2008) page 1 http://www.nmc-uk.org/Nursesand-midwives/Standards-and-guidance1/The-code/The-code-in-full/ states “As a
professional, you are personally accountable for actions and omissions in your
121002 Intro to PGDs October 2012 v1
practice and must always be able to justify your decisions.” Giving an immunisation
without consent could leave the health professional vulnerable to legal action and
action by their regulatory body.
Who can give consent
Adults
Adults are those aged 18 or over. An adult must consent to their own treatment.
Under English law, no one is able to give consent on behalf of an adult unable to give
consent for examination or treatment him or herself. The Mental Capacity Act 2005
sets out how treatment decisions should be made for people of 16 years of age or
older who do not have the capacity to make such decisions (more information will be
available at www.dh.gov.uk/consent ).
If an adult has refused immunisation before losing the capacity to make a decision,
this decision will be legally binding, provided that it remains valid and applicable to
the circumstances. If an adult has not clearly refused the treatment before losing the
capacity to make such a decision, you will be able to treat an adult who is unable to
give consent if the treatment would be in their best interests, e.g. in a nursing home
situation where the risk of influenza could compromise the individual’s health. This
decision would be made by the patient’s doctor in discussion with those close to the
patient.
Routine Immunisation in school/competency
Where immunisations are routinely offered in the school setting, the situation differs
depending on the age and competence of the individual child or young person.
Information leaflets should be available for the child’s own use and to share with their
parents prior to the date that the immunisation is scheduled.
Young people aged 16 and 17 are presumed, in law, to be able to consent to their
own medical treatment. Younger children who understand fully what is involved in the
proposed procedure (Gillick competent as outlined in the Fraser Guidelines) can also
give consent, although ideally their parents will be involved.
If a person aged 16 or 17 or a child competent under the Fraser Guidelines consents
to treatment, a parent cannot override that consent.
If the health professional giving the immunisation felt a child was not competent
under the Fraser guidelines then the consent of someone with parental responsibility
would be sought.
If a person aged 16 or 17 or a competent child competent under the Fraser
Guidelines refuses treatment that refusal should be accepted. It is unlikely that a
person with parental responsibility could overrule such a refusal. It is possible that
the court might overrule a young person’s refusal if an application to court is made
under section 8 of the Children Act 1989 or the inherent jurisdiction of the High Court.
There is no requirement for consent to be in writing.
121002 Intro to PGDs October 2012 v1
Who has parental responsibility
Mothers automatically have parental responsibility for their children.
Fathers also have parental responsibility if they were married to the mother when the
child was conceived or born, or if he married her later. By law, unmarried fathers do
not automatically have parental responsibility and before 1st December 2003 they
could only obtain this by:



Parental responsibility order granted by the court.
Residence order granted by the court.
Parental responsibility agreement (this must be signed by both parents,
their signature witnessed by an officer of the court or a magistrate)
Since 1st December 2003 unmarried father’s who is the natural father of the child can
also acquire parental responsibility if he is named as the father on the child’s birth
certificate.
A step parent may acquire parental responsibility of a child where s/he is married to,
or a civil partner of, the child’s parent who has parental responsibility and either (i)
there is a parental responsibility agreement to this effect or (ii) the court grants a
parental responsibility order (see Section 4A of the Children Act 1989).
Although the consent of one person with parental responsibility for a child is usually
sufficient (see Section 2(7) of the Children Act 1989), if one parent agrees to
immunisation but the other disagrees, the immunisation should not be carried out
unless both parents can agree to immunisation or there is a specific court approval
that the immunisation is in the best interests of the child.
Children may be brought for immunisation by a person without parental responsibility,
for example, a grandparent or childminder. Where a child is brought for immunisation
by some one who does not have parental responsibility the health professional would
need to be satisfied that:


The person with parental responsibility has consented in advance to the
immunisation (i.e. they received all the relevant information in advance and
arranged for the other person to bring the child to the appointment) or
The person with parental responsibility has arranged for this other person to
provide the necessary consent (i.e. they asked the other person to take the
child to the appointment, to consider any further information given by the
health professional, and then to agree to immunisation if appropriate).
If there is any evidence that the person with parental responsibility:

May not have agreed to the immunisation (e.g. the notes indicate that the
parent(s) may have negative views on immunisation), or
121002 Intro to PGDs October 2012 v1

May not have agreed that the person bringing the child could give the
necessary consent (e.g. suggestion of disagreements between the parents on
medical matters) then the person with parental responsibility should be
contacted for their consent. If there is disagreement between the people with
parental responsibility for the child, then immunisation should not be carried
out until their dispute is resolved.
Further guidance on consent can be found at:
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAnd
Guidance/DH_4005762 and in the Green Book Chapter 2.
Purpose of the Patient Group Directions
PGDs are defined as written instructions for the supply or administration of medicines
to groups of patients who may not be individually identified before presentation for
treatment (SI 2000/1917). PGDs are not a form of prescribing but provide a legal
framework for the supply and/or administration of medicines by a range of qualified
healthcare professionals e.g. nurses. Employing organisations must ensure that all
users of PGDs are fully competent and trained in their use.
These Patient Group Directions apply to all nurses and delegating GPs working in
NHS North Staffordshire or NHS Stoke-on-Trent, wherever immunisation is given.
Characteristics of Staff
Qualifications
Required
Continuing
Training
Requirements








Additional
Requirements



Registered nurse with current registration with the NMC
Vaccination and Immunisation Training
CPR and anaphylaxis training
Vaccination and Immunisation training and CPR and
anaphylaxis training is a mandatory pre requisite to give
vaccines by a PGD. These should be attended annually.
However, at a minimum training should be complete at
intervals of a maximum period of 18 months.
If a new vaccine or programme is introduced, appropriate
specific training must be attended.
Peer and self assessment is required until competent to
administer immunisations.
To read and understand the PGDs for the administration of
immunisation.
Signed agreement for each PGD to be completed by the
Practitioner and PCT Manager/GP for each vaccination to
be given.
Immediate access to adrenaline (epinephrine) 1:1000
All who immunise must be competent to recognise and
advise on the management of adverse reactions as
detailed in the Green Book and manufacturer’s Summary
of Product Characteristics (SPC)
Access to ‘Immunisation against Infectious Disease’
(Green Book) and compliance with its recommendations.
121002 Intro to PGDs October 2012 v1


For Black Triangle drugs, all adverse drug reactions
(ADRs) should be reported. For other drugs significant
ADRs only need be reported.
Patients with suspected ADRs should be referred to an
appropriate doctor for investigation. If appropriate a report
should be made using a yellow card (copies in the BNF) to
the Medicines and Healthcare products Regulatory
Agency.
The difference between prescribing and Patient Group Directions
Independent prescribers can give a documented Patient Specific Direction (PSD),
which instructs another healthcare professional to supply or administer a medicine to
a specified patient.
Alternatively, a Patient Group Direction (PGD) is a legal mechanism that allows
named registered healthcare professionals to supply and/or administer medicines to
groups of patients that fit the criteria laid out in the PGD. So a healthcare
professional could supply (e.g. provide an inhaler or tablets) and/or administer a
medicine (e.g. give an injection or a suppository) directly to a patient without the need
for a prescription or an instruction from a prescriber. Using a PGD is not a form of
prescribing.
Confusion can arise about the difference between a PGD and the other mechanisms
for prescribing, supply and administration of medicines, and which is the most
appropriate for the particular circumstances.
When a prescriber sees a patient, and following assessment and diagnosis, decides
that a medicine is needed as part of the treatment plan; in the majority of cases, a
prescription is issued. A pharmacist then dispenses the medicine against the
prescription and the patient receives their medicine. Medicines law recognises the
value of pharmacists in the checking and dispensing process and this is the main
route by which patients get their medicines. However, in some cases, it may be
necessary or convenient for a patient to receive a medicine (i.e. have it supplied
and/or administered) directly from another healthcare professional. Unless already
covered by exemptions to the Medicines Act, there are two ways of achieving this; by
Patient Specific Direction (PSD) or Patient Group Direction (PGD).
A PSD is used once a patient has been assessed by a prescriber and that prescriber,
(doctor, dentist or other independent prescriber) instructs another healthcare
professional in writing to supply or administer a medicine directly to that named
patient or, to several named patients (e.g. patients on a clinic list). A PSD is a direct
instruction and does not require an assessment of the patient by the healthcare
professional instructed to supply and/or administer, unlike a PGD. It is the
responsibility of the person issuing the PSD to ensure that the individual supplying or
administering the medicine is competent to do so.
For further information on the difference between a Patient Group Direction (PGD)
and a Patient Specific Direction please refer to the NPC document:
121002 Intro to PGDs October 2012 v1
Patient Group Directions December 2009 - A practical guide and framework of
competencies for all professionals using patient group directions.
http://www.npc.nhs.uk/non_medical/resources/patient_group_directions.pdf
Travel Health and excluded vaccines
Any vaccines not included within these PGDs please refer to the Green Book.
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAnd
Guidance/DH_079917
Inclusion criteria for certain PGDs
The SPC for some vaccines means that off-licence recommendations are included.
However, the recommendations in these PGDs are in line with Joint Committee on
Vaccination and Immunisation (JCVI) guidance as contained in Green Book chapters
and represent best clinical practice.
Development Team
These PGDs contained in the set are based on the previous PGD document “Patient
Group Directions for the Administration of Immunisations within Primary Care,
(PGD/VI/SEPT/2010, Issued 1 October 2010. Review Date 1 October 2012 V1.02
Amended July 2011.)
Development team details for original draft
The Patient Group Directions were originally developed for use in the North
Staffordshire Health Economy by the following multi-disciplinary team:
Dr James Bashford
Mrs Julia Briscoe
Ms Jan Butterworth
Dr Philippa Dove
Ms Catherine Jackson
Dr Margaret Jones
Mrs Jacqueline Kinsey
Dr David Phillips
Ms Sandra Sheppard
Dr Hilary Thurston
Ms Diane Walton
Mrs Pat Wheeler
Mrs Angela Willdigg
Dr Hilary Thurston
Dr John Chesworth
Ms Catherine Jackson
Ms Jacqueline Kinsey
Ms Rose Dent
Mrs Angela Willdigg
121002 Intro to PGDs October 2012 v1
Chairman, District Prescribing Advisory Group
Nurse Adviser NSHA
Community Pharmacy Facilitator
Clinical Governance Lead Newcastle PCG
Senior Pharmacist Community Services
Medical Director NSHA
Pharmaceutical Adviser NSHA
Prescribing Lead Central Stoke PCG
Practice Nurse, Harley St Surgery
Consultant in Communicable Disease NSHA
Combined Health Care
Community Manager, Newcastle PCT
Senior Nurse Manager
Consultant in Communicable Disease NSHA
Medical Adviser
Senior Pharmacist Community Services
Pharmaceutical Adviser
Practise Nurse Developer
Senior Nurse Manager
Update September 2008
The Patient Group Directions were reviewed and updated by the following
multidisciplinary group:
Dr David Prayle
Dr John Chesworth
Sarah Sellars
Melanie Brock
Sue Forrester-O’Neil
Allison Minshall
Senior Community Medicines Advisor, NHS North
Staffordshire
Medial Director, NHS North Staffordshire
Specialist Nurse Practitioner, High Street Practice
School Nurse Professional Lead, North
Staffordshire Provider Services
District Nurse Lead, North Staffordshire Provider
Services
Professional Lead for Practice Nursing, NHS Stoke
on Trent
Update October 2009
The Patient Group Directions were reviewed and updated by the following
multidisciplinary group:
Dr Manir Hussain
Emma Maddocks
Allison Minshall
Head of Medicines Management, NHS North
Staffordshire
Medicines Management Pharmacist, NHS Stoke on
Trent
PCT Vaccine and Immunisation Lead/
Co-ordinator, NHS Stoke on Trent
Update March 2010
The Patient Group Directions were reviewed and updated by the following
multidisciplinary group:
Dr Manir Hussain
Emma Maddocks
Sandra Guerrero
Allison Minshall
Head of Medicines Management, NHS North
Staffordshire
Medicines Management Pharmacist, NHS Stoke on
Trent
Prescribing Advisor, NHS North Staffordshire
PCT Vaccine and Immunisation Lead/
Co-ordinator, NHS Stoke on Trent
Full review July – November 2010
The PGDs contained in this set were reviewed by the following multidisciplinary
group:
Dr John Chesworth
Mara Cope
121002 Intro to PGDs October 2012 v1
Medial Director, NHS North Staffordshire
Prescribing Advisor, NHS North Staffordshire
Emma Maddocks
Allison Minshall
Liesa Coleclough
Chris McGrath
Rachel Shaw
Margaret Welch
Medicines Management Pharmacist, NHS Stoke on
Trent
PCT Vaccine and Immunisation Lead/
Co-ordinator, NHS Stoke on Trent
Medicines Management Technician, NHS North
Staffordshire
Health Visitor, NHS North Staffordshire
Health Visiting Team, NHS North Staffordshire
Head of Medicines Management, Stoke-on-Trent
Community Health Service.
Update January 2011
The Patient Group Directions were reviewed and updated by the following
multidisciplinary group:
Mara Cope
Prescribing Advisor, NHS North Staffordshire
Emma Maddocks
Medicines Management Pharmacist, NHS Stoke on
Trent
Allison Minshall
PCT Vaccine and Immunisation Lead/
Co-ordinator, NHS Stoke on Trent
Update July 2011
The Patient Group Directions were reviewed and updated by the following
multidisciplinary group:
Mara Cope
Prescribing Advisor, North Staffordshire CCG
Emma Dasey (née Maddocks)
Medicines Management Pharmacist, Stoke on
Trent CCG
Allison Minshall
PCT Vaccine and Immunisation Lead/
Co-ordinator, NHS Stoke on Trent
Full review July 2012 (Repevax in pregnancy added October 2012)
Caroline Acuda
Prescribing Advisor, North Staffordshire CCG
Fiona Riley
Prescribing Advisor, Stoke on Trent CCG
Emma Dasey
Prescribing Advisor, Stoke on Trent CCG
Allison Minshall
PCT Vaccine and Immunisation Lead/
Co-ordinator, NHS Stoke on Trent
121002 Intro to PGDs October 2012 v1
References
Immunisation Against Infectious Diseases DOH
http://immunisation.dh.gov.uk/category/the-green-book/
Department of Health (1998): Review of Prescribing, Supply and Administration of
Medicines. A report on the Supply and Administration of Medicines under Group
Protocol.
Department of Health (2001): Good practice in consent implementation guide:
consent to examination or treatment
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAnd
Guidance/DH_4005762
NMC standards for Medicines Management 2008 http://www.nmcuk.org/Documents/NMCPublications/238747_NMC_Standards_for_medicines_management.pdf
NMC 2008 The code http://www.nmc-uk.org/Nurses-and-midwives/Standards-andguidance1/The-code/The-code-in-full/
Health Service Circular (1998) HSC.98/051. Report on the Supply and
Administration of Medicines under Group Protocols
Health Service Circular 2000/26 - Patient Group Directions
UK Guidance on Best Practice in Vaccine Administration 2001
http://www.rcn.org.uk/__data/assets/pdf_file/0010/78562/001981.pdf
121002 Intro to PGDs October 2012 v1
Patient Group Directions included in this set are:
PGD
Number
1
2
3a
3b
4
5a
5b
6
7a
7b
8
9
10
11
12
13
14a
14b
15
16
17
18
19
20
21
22a
22b
23
Immunisation PGD name
MMR - MEASLES, MUMPS AND RUBELLA LIVE
VACCINE(MMR)
INACTIVATED INFLUENZA VACCINE
MENINGOCOCCAL A,C,W 135,Y CONJUGATE VACCINE
(MENACWY) MENVEO®▼
MENINGOCOCCAL A,C,W 135,Y CONJUGATE VACCINE
(MENACWY) ACWY VAX®
PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23
VALENT) (PPV)
HEPATITIS A FOR CHILDREN
HEPATITIS A FOR CHILDREN (VAQTA
PAEDIATRIC®)
Reference and version
number for PGD
1MMRv1
2Influenzav1
3aMenACWYMenveov1
3bMenACWYVaxv1
4PPVv1
5aHepAchildv1
5bHepAchildVaqtaPaedv1
HEPATITIS A FOR ADULTS
6HepAadultv1
TYPHOID FEVER
7aTyphoidv1
TYPHOID FEVER ORAL
(VIVOTIF®
CAPSULES)
MENINGOCOCCAL GROUP C CONJUGATE VACCINE
7bTyphoidoralVivotifv1
8MenCv1
HEPATITIS B VACCINE FOR ADULTS
9HepBadultsv1
HEPATITIS B VACCINE FOR CHILDREN
10HepBchildv1
HEPATITIS A (INACTIVATED) AND HEPATITIS B (RDNA)
(HAB) VACCINE (ADSORBED) TWINRIX® ADULT
HEPATITIS A (INACTIVATED) AND HEPATITIS B (RDNA)
(HAB) VACCINE (ADSORBED) TWINRIX® PAEDIATRIC
HEPATITIS A (INACTIVATED) AND HEPATITIS B(RDNA)
(HAB) VACCINE (ADSORBED) FOR CHILDREN
AMBIRIX®
HEPATITIS A (INACTIVATED, ABSORBED ) AND
TYPHOID POLYSACCHARIDE VACCINE HEPATYRIX®
HEPATITIS A (INACTIVATED, ABSORBED ) AND
TYPHOID POLYSACCHARIDE VACCINE VIATIM®
OXYGEN
ADRENALINE (EPINEPHRINE) 1MG/1ML INJECTION
11HepABtwinadultv1
12HepABtwinchildv1
13HepABambirixv1
14aHepatyrixv1
14bViatimv1
15Oxygenv1
16Adrenalinev1
DIPHTERIA, TETANUS/ACELLULAR PERTUSSIS,
INACTIVATED POLIO VACCINE AND HIB (DTaP/IPV/Hib)
PEDIACEL®
DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR
COMPONENT) AND POLIOMYELITIS (INACTIVATED)
VACCINE - REPEVAX® / INFANRIX-IPV
DIPHTHERIA, TETANUS AND INACTIVATED POLIO
VACCINE Td/IPV (REVAXIS®)
PNEUMOCOCCAL POLYSACCARIDE CONJUGATE
VACICNE (13-VALENT, ADSORBED) PREVENAR 13®▼
HAEMOPHILUS INFLUENZAE TYPE B AND
MENINGOCOCCAL C CONJUGATE VACCINE MENITORIX®
HUMAN PAPILLOMAVIRUS (HPV) CERVARIX®
22aHPVCervarixv1
HUMAN PAPILLOMAVIRUS (HPV) GARDASIL® ▼
22bHPVGardasilv1
LOW DOSE DIPHTHERIA, TETANUS, ACELLULAR
PERTUSSIS AND INACTIVATED POLIOMYELITIS
VACCINE - REPEVAX® FOR PREGNANT WOMEN
121002 Intro to PGDs October 2012 v1
17Pediacelv1
18Rep/Infanv1
19Revaxisv1
20Prevenarv1
21Menitorixv1
23Repevax_Pregnancy_v1
Please note that there are two PGDs for certain vaccines, e.g. HPV vaccines.
In some cases vaccines are not interchangeable – please refer to the relevant
PGD and SPC.
Please ensure you are familiar with the content of these PGDs and select the
vaccines with care.
121002 Intro to PGDs October 2012 v1